310 related articles for article (PubMed ID: 30327364)
21. Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.
Graessler J; Bornstein TD; Goel D; Bhalla VP; Lohmann T; Wolf T; Koch M; Qin Y; Licinio J; Wong ML; Chavakis T; Xu A; Shevchenko A; Schuhmann K; Schwarz PE; Schulte KM; Patel A; Bornstein SR
Pharmacogenomics J; 2014 Jun; 14(3):201-7. PubMed ID: 24365785
[TBL] [Abstract][Full Text] [Related]
22. Gestational Diabetes Mellitus, Postpartum Lipidomic Signatures, and Subsequent Risk of Type 2 Diabetes: A Lipidome-Wide Association Study.
Wang G; Buckley JP; Bartell TR; Hong X; Pearson C; Wang X
Diabetes Care; 2023 Jun; 46(6):1223-1230. PubMed ID: 37043831
[TBL] [Abstract][Full Text] [Related]
23. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk.
Díaz-López A; Bulló M; Martínez-González MA; Corella D; Estruch R; Fitó M; Gómez-Gracia E; Fiol M; García de la Corte FJ; Ros E; Babio N; Serra-Majem L; Pintó X; Muñoz MÁ; Francés F; Buil-Cosiales P; Salas-Salvadó J
Eur J Nutr; 2016 Feb; 55(1):349-60. PubMed ID: 25663611
[TBL] [Abstract][Full Text] [Related]
24. Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial.
Yu E; Ruiz-Canela M; Razquin C; Guasch-Ferré M; Toledo E; Wang DD; Papandreou C; Dennis C; Clish C; Liang L; Bullo M; Corella D; Fitó M; Gutiérrez-Bedmar M; Lapetra J; Estruch R; Ros E; Cofán M; Arós F; Romaguera D; Serra-Majem L; Sorlí JV; Salas-Salvadó J; Hu FB; Martínez-González MA
Diabetes Obes Metab; 2019 Feb; 21(2):397-401. PubMed ID: 30146690
[TBL] [Abstract][Full Text] [Related]
25. Circulating Glycerolipids, Fatty Liver Index, and Incidence of Type 2 Diabetes: A Prospective Study Among Chinese.
Niu Z; Wu Q; Sun L; Qi Q; Zheng H; Li H; Zeng R; Lin X; Zong G
J Clin Endocrinol Metab; 2021 Jun; 106(7):2010-2020. PubMed ID: 33711157
[TBL] [Abstract][Full Text] [Related]
26. Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial.
Ruiz-Canela M; Guasch-Ferré M; Toledo E; Clish CB; Razquin C; Liang L; Wang DD; Corella D; Estruch R; Hernáez Á; Yu E; Gómez-Gracia E; Zheng Y; Arós F; Romaguera D; Dennis C; Ros E; Lapetra J; Serra-Majem L; Papandreou C; Portoles O; Fitó M; Salas-Salvadó J; Hu FB; Martínez-González MA
Diabetologia; 2018 Jul; 61(7):1560-1571. PubMed ID: 29663011
[TBL] [Abstract][Full Text] [Related]
27. Plasma metals and cardiovascular disease in patients with type 2 diabetes.
Long T; Wang R; Wang J; Wang F; Xu Y; Wei Y; Zhou L; Zhang X; Yuan J; Yao P; Wei S; Guo H; Yang H; Wu T; He M
Environ Int; 2019 Aug; 129():497-506. PubMed ID: 31158596
[TBL] [Abstract][Full Text] [Related]
28. Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study.
Brahimaj A; Ligthart S; Ikram MA; Hofman A; Franco OH; Sijbrands EJ; Kavousi M; Dehghan A
Diabetes Care; 2017 Mar; 40(3):346-351. PubMed ID: 28031419
[TBL] [Abstract][Full Text] [Related]
29. Plasma Lipidome and Prediction of Type 2 Diabetes in the Population-Based Malmö Diet and Cancer Cohort.
Fernandez C; Surma MA; Klose C; Gerl MJ; Ottosson F; Ericson U; Oskolkov N; Ohro-Melander M; Simons K; Melander O
Diabetes Care; 2020 Feb; 43(2):366-373. PubMed ID: 31818810
[TBL] [Abstract][Full Text] [Related]
30. Dairy consumption, plasma metabolites, and risk of type 2 diabetes.
Drouin-Chartier JP; Hernández-Alonso P; Guasch-Ferré M; Ruiz-Canela M; Li J; Wittenbecher C; Razquin C; Toledo E; Dennis C; Corella D; Estruch R; Fitó M; Eliassen AH; Tobias DK; Ascherio A; Mucci LA; Rexrode KM; Karlson EW; Costenbader KH; Fuchs CS; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J; Hu FB
Am J Clin Nutr; 2021 Jul; 114(1):163-174. PubMed ID: 33742198
[TBL] [Abstract][Full Text] [Related]
31. Detection of Independent Associations of Plasma Lipidomic Parameters with Insulin Sensitivity Indices Using Data Mining Methodology.
Kopprasch S; Dheban S; Schuhmann K; Xu A; Schulte KM; Simeonovic CJ; Schwarz PE; Bornstein SR; Shevchenko A; Graessler J
PLoS One; 2016; 11(10):e0164173. PubMed ID: 27736893
[TBL] [Abstract][Full Text] [Related]
32. Genetic correlation of the plasma lipidome with type 2 diabetes, prediabetes and insulin resistance in Mexican American families.
Kulkarni H; Mamtani M; Wong G; Weir JM; Barlow CK; Dyer TD; Almasy L; Mahaney MC; Comuzzie AG; Duggirala R; Meikle PJ; Blangero J; Curran JE
BMC Genet; 2017 May; 18(1):48. PubMed ID: 28525987
[TBL] [Abstract][Full Text] [Related]
33. Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts.
Mamtani M; Kulkarni H; Wong G; Weir JM; Barlow CK; Dyer TD; Almasy L; Mahaney MC; Comuzzie AG; Glahn DC; Magliano DJ; Zimmet P; Shaw J; Williams-Blangero S; Duggirala R; Blangero J; Meikle PJ; Curran JE
Lipids Health Dis; 2016 Apr; 15():67. PubMed ID: 27044508
[TBL] [Abstract][Full Text] [Related]
34. Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: a nested case-control study.
Díaz-López A; Chacón MR; Bulló M; Maymó-Masip E; Martínez-González MA; Estruch R; Vendrell J; Basora J; Díez-Espino J; Covas MI; Salas-Salvadó J
J Clin Endocrinol Metab; 2013 Aug; 98(8):3482-90. PubMed ID: 23760626
[TBL] [Abstract][Full Text] [Related]
35. Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.
Alshehry ZH; Mundra PA; Barlow CK; Mellett NA; Wong G; McConville MJ; Simes J; Tonkin AM; Sullivan DR; Barnes EH; Nestel PJ; Kingwell BA; Marre M; Neal B; Poulter NR; Rodgers A; Williams B; Zoungas S; Hillis GS; Chalmers J; Woodward M; Meikle PJ
Circulation; 2016 Nov; 134(21):1637-1650. PubMed ID: 27756783
[TBL] [Abstract][Full Text] [Related]
36. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
Guasch-Ferré M; Hu FB; Ruiz-Canela M; Bulló M; Toledo E; Wang DD; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Lapetra J; Fitó M; Arós F; Serra-Majem L; Ros E; Dennis C; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080862
[TBL] [Abstract][Full Text] [Related]
37. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.
de Mello VD; Paananen J; Lindström J; Lankinen MA; Shi L; Kuusisto J; Pihlajamäki J; Auriola S; Lehtonen M; Rolandsson O; Bergdahl IA; Nordin E; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Landberg R; Eriksson JG; Tuomilehto J; Hanhineva K; Uusitupa M
Sci Rep; 2017 Apr; 7():46337. PubMed ID: 28397877
[TBL] [Abstract][Full Text] [Related]
38. Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes - A nested case-control study.
Schillemans T; Shi L; Donat-Vargas C; Hanhineva K; Tornevi A; Johansson I; Koponen J; Kiviranta H; Rolandsson O; Bergdahl IA; Landberg R; Åkesson A; Brunius C
Environ Int; 2021 Jan; 146():106180. PubMed ID: 33113464
[TBL] [Abstract][Full Text] [Related]
39. Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study.
Huth C; Bauer A; Zierer A; Sudduth-Klinger J; Meisinger C; Roden M; Peters A; Koenig W; Herder C; Thorand B
Cardiovasc Diabetol; 2020 Mar; 19(1):32. PubMed ID: 32164753
[TBL] [Abstract][Full Text] [Related]
40. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
